The global market for endoscopic retrograde cholangiopancreatography (ERCP) devices is set to experience significant growth over the next decade, with estimates predicting sales to increase from USD 1 ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...
Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...
Esophageal Implant MarketThe global esophageal implant market is set for substantial growth, with its valuation projected to reach USD 147 million in 2023. Over the next decade, the market is ...